Your session is about to expire
← Back to Search
Balloon Inflation Techniques for Coronary Artery Disease (INFLATION/DE Trial)
N/A
Waitlist Available
Led By Barry F Uretsky, M.D.
Research Sponsored by Central Arkansas Veterans Healthcare System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up intra-procedure and first hour post-pci
Awards & highlights
INFLATION/DE Trial Summary
This trial is testing whether prolonged balloon inflation or rapid inflation/deflation is more effective in deploying a coronary balloon-expandable stent.
Who is the study for?
This trial is for adults over 18 with coronary artery disease who need a single stent placed in an artery that's 2.5-3.5 mm wide and can have OCT imaging done to check the stent's placement. It's not for those in shock, with severe kidney issues, certain heart attacks, completely blocked arteries, complex stenting needs or unable to consent.Check my eligibility
What is being tested?
The study compares two ways of putting a stent in: one uses prolonged high-pressure balloon inflation until pressure stabilizes (which could take several minutes), and the other uses rapid inflation/deflation (lasting about 15-30 seconds). The goal is to see which method better expands the stent against the artery wall.See study design
What are the potential side effects?
While specific side effects are not listed for this procedure-focused trial, potential risks may include discomfort at the inflation site, bleeding complications from prolonged pressure application or vessel damage due to overexpansion.
INFLATION/DE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 1 within first hour after stent deployment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 within first hour after stent deployment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Minimal lumen stent diameter
Minimal luminal stent area
Number of unapposed stent struts
Secondary outcome measures
% of patients with complete stent apposition
Number of unapposed stent struts/mm of stent
Cardiac Arrhythmia
+1 moreINFLATION/DE Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: ProlongedExperimental Treatment1 Intervention
Prolonged inflation will be performed at high pressure(16 atm)and maintained for 30 sec with <0.3 atm drop during that period.
Group II: RapidActive Control1 Intervention
The rapid inflation method will consist of reaching an operator determined high-pressure (16 atm) with the stent-deployment balloon and maintaining it the duration of time determined by the operator but <30 sec if the balloon is fully inflated and longer only if the balloon requires a longer duration to become fully inflated.
Find a Location
Who is running the clinical trial?
Central Arkansas Veterans Healthcare SystemLead Sponsor
23 Previous Clinical Trials
3,500 Total Patients Enrolled
2 Trials studying Coronary Artery Disease
1,700 Patients Enrolled for Coronary Artery Disease
Barry F Uretsky, M.D.Principal InvestigatorCentral Arkansas Veterans' Healthcare System
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had a severe type of heart attack.I have a completely blocked artery.My heart's artery has a branch larger than 2.5 mm in the area that was stented.I do not have a condition causing very low blood pressure due to heart problems.I am unable to understand and give consent for treatment.I have a blockage in the main artery of my heart.My kidney function is low with creatinine over 1.8 mg/dL.You need more than one stent placed in the same area.I am over 18, have coronary disease, and need a stent for a 2.5-3.5 mm lesion.
Research Study Groups:
This trial has the following groups:- Group 1: Rapid
- Group 2: Prolonged
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger